Patents Assigned to Hemotek Medical Incorporated
-
Publication number: 20240074829Abstract: Tissue access devices and methods of using the same are disclosed. The devices can have a sensor configured to occlude a flow path by deflecting a membrane into the flow path when the devices become dislodged from tissue. The sensor can be configured to partially or fully occlude the flow path. The sensor can have a spring. The spring can be biased to move the sensor from a sensor first configuration to a sensor second configuration when a force applied by the sensor first surface against a non-sensor surface changes from a first force to a second force less than the first force. The membrane can be deflected into the flow path when the sensor is in the sensor second configuration.Type: ApplicationFiled: November 9, 2023Publication date: March 7, 2024Applicant: Hemotek Medical IncorporatedInventors: Patrick ROUSCHE, Peter TEK, Charles VENTURA, Richard A. SCRIBNER, Andrew BLACK, Andrew LEOPOLD, Mark CARLSON, Todd MACY, Daniel LANE, Adam HENSEL, Edward BROWKA
-
Publication number: 20240075205Abstract: Tissue access devices and methods of using and making the same are disclosed. The devices can have a sensor configured to occlude a flow path by deflecting a membrane into the flow path when the devices become dislodged from tissue. The sensor can be configured to partially or fully occlude the flow path. The sensor can have a spring, can be a spring, or may not have a spring. The sensor can be static or can be moved from a sensor first configuration to a sensor second configuration. The membrane can be deflected into the flow path when the sensor is in the sensor second configuration.Type: ApplicationFiled: October 26, 2023Publication date: March 7, 2024Applicant: Hemotek Medical IncorporatedInventors: Patrick ROUSCHE, Charles VENTURA, Adam HENSEL, Todd MACY, Richard A. SCRIBNER
-
Publication number: 20230056293Abstract: Tissue access devices and methods of using the same are disclosed. The devices can have a sensor configured to occlude a flow path by deflecting a membrane into the flow path when the devices become dislodged from tissue. The sensor can be configured to partially or fully occlude the flow path. The sensor can have a spring. The spring can be biased to move the sensor from a sensor first configuration to a sensor second configuration when a force applied by the sensor first surface against a non-sensor surface changes from a first force to a second force less than the first force. The membrane can be deflected into the flow path when the sensor is in the sensor second configuration.Type: ApplicationFiled: August 16, 2022Publication date: February 23, 2023Applicant: Hemotek Medical IncorporatedInventors: Patrick ROUSCHE, Peter TEK, Charles VENTURA, Richard A. SCRIBNER, Andrew BLACK, Andrew LEOPOLD, Mark CARLSON, Todd MACY, Daniel LANE, Adam HENSEL, Edward BROWKA
-
Publication number: 20220354610Abstract: Tissue access devices and methods of using and making the same are disclosed. The devices can have a needle, a housing having wings, a tube having a flow channel, a tube first extension, and a tube second extension, and a torsion spring having a first coil and a second coil. The first coil can have a first coil first arm and a first coil second arm. The first coil first arm can be shorter than the first coil second arm. The second coil can have a second coil first arm and a second coil second arm. The second coil first arm can be shorter than the second coil second arm. The devices can have a sensor. More energy can stored in the torsion spring when the sensor is in a sensor closed configuration than when the sensor is in a sensor open configuration.Type: ApplicationFiled: February 14, 2022Publication date: November 10, 2022Applicant: Hemotek Medical IncorporatedInventors: Patrick ROUSCHE, Charles VENTURA, Adam HENSEL, Todd MACY, Edward BROWKA
-
Patent number: 11446110Abstract: Tissue access devices and methods of using the same are disclosed. The devices can have a sensor configured to occlude a flow path by deflecting a membrane into the flow path when the devices become dislodged from tissue. The sensor can be configured to partially or fully occlude the flow path. The sensor can have a spring. The spring can be biased to move the sensor from a sensor first configuration to a sensor second configuration when a force applied by the sensor first surface against a non-sensor surface changes from a first force to a second force less than the first force. The membrane can be deflected into the flow path when the sensor is in the sensor second configuration.Type: GrantFiled: June 20, 2019Date of Patent: September 20, 2022Assignee: Hemotek Medical IncorporatedInventors: Patrick Rousche, Peter Tek, Charles Ventura, Richard A. Scribner, Andrew Black, Andrew Leopold, Mark Carlson, Todd Macy, Daniel Lane, Adam Hensel, Edward Browka
-
Publication number: 20210228802Abstract: Systems and methods for automatic flow termination for fluid delivery, including a housing configured for coupling a fluid delivery tube to a needle configured for subcutaneous delivery of fluid within a tissue of a patient and a spring-loaded activation mechanism having a first orientation corresponding to a condition where the housing is disposed substantially adjacent to the tissue and the needle lodged within the tissue and a second orientation corresponding to a condition where the housing is disposed away from the tissue or the needle being dislodged from the tissue. A flow termination mechanism is coupled to the activation mechanism and having an open configuration allowing flow from the fluid delivery tube to the needle when the activation mechanism is in the first orientation and a closed configuration substantially terminating flow from the fluid delivery tube to the needle when the activation mechanism is in the second orientation.Type: ApplicationFiled: April 16, 2021Publication date: July 29, 2021Applicant: Hemotek Medical IncorporatedInventors: Patrick Rousche, Peter Tek, Charles Ventura, Richard A. Scribner
-
Patent number: 10994075Abstract: Systems and methods for automatic flow termination for fluid delivery, including a housing configured for coupling a fluid delivery tube to a needle configured for subcutaneous delivery of fluid within a tissue of a patient and a spring-loaded activation mechanism having a first orientation corresponding to a condition where the housing is disposed substantially adjacent to the tissue and the needle lodged within the tissue and a second orientation corresponding to a condition where the housing is disposed away from the tissue or the needle being dislodged from the tissue. A flow termination mechanism is coupled to the activation mechanism and having an open configuration allowing flow from the fluid delivery tube to the needle when the activation mechanism is in the first orientation and a closed configuration substantially terminating flow from the fluid delivery tube to the needle when the activation mechanism is in the second orientation.Type: GrantFiled: January 10, 2019Date of Patent: May 4, 2021Assignee: Hemotek Medical IncorporatedInventors: Patrick Rousche, Peter Tek, Charles Ventura, Richard A. Scribner
-
Publication number: 20190143033Abstract: Systems and methods for automatic flow termination for fluid delivery, including a housing configured for coupling a fluid delivery tube to a needle configured for subcutaneous delivery of fluid within a tissue of a patient and a spring-loaded activation mechanism having a first orientation corresponding to a condition where the housing is disposed substantially adjacent to the tissue and the needle lodged within the tissue and a second orientation corresponding to a condition where the housing is disposed away from the tissue or the needle being dislodged from the tissue. A flow termination mechanism is coupled to the activation mechanism and having an open configuration allowing flow from the fluid delivery tube to the needle when the activation mechanism is in the first orientation and a closed configuration substantially terminating flow from the fluid delivery tube to the needle when the activation mechanism is in the second orientation.Type: ApplicationFiled: January 10, 2019Publication date: May 16, 2019Applicant: Hemotek Medical IncorporatedInventors: Patrick ROUSCHE, Peter TEK, Charles VENTURA, Richard A. SCRIBNER
-
Patent number: 10213548Abstract: Systems and methods for automatic flow termination for fluid delivery, including a housing configured for coupling a fluid delivery tube to a needle configured for subcutaneous delivery of fluid within a tissue of a patient and a spring-loaded activation mechanism having a first orientation corresponding to a condition where the housing is disposed substantially adjacent to the tissue and the needle lodged within the tissue and a second orientation corresponding to a condition where the housing is disposed away from the tissue or the needle being dislodged from the tissue. A flow termination mechanism is coupled to the activation mechanism and having an open configuration allowing flow from the fluid delivery tube to the needle when the activation mechanism is in the first orientation and a closed configuration substantially terminating flow from the fluid delivery tube to the needle when the activation mechanism is in the second orientation.Type: GrantFiled: October 5, 2016Date of Patent: February 26, 2019Assignee: Hemotek Medical IncorporatedInventors: Patrick Rousche, Peter Tek, Charles Ventura, Richard A. Scribner
-
Publication number: 20170021098Abstract: Systems and methods for automatic flow termination for fluid delivery, including a housing configured for coupling a fluid delivery tube to a needle configured for subcutaneous delivery of fluid within a tissue of a patient and a spring-loaded activation mechanism having a first orientation corresponding to a condition where the housing is disposed substantially adjacent to the tissue and the needle lodged within the tissue and a second orientation corresponding to a condition where the housing is disposed away from the tissue or the needle being dislodged from the tissue. A flow termination mechanism is coupled to the activation mechanism and having an open configuration allowing flow from the fluid delivery tube to the needle when the activation mechanism is in the first orientation and a closed configuration substantially terminating flow from the fluid delivery tube to the needle when the activation mechanism is in the second orientation.Type: ApplicationFiled: October 5, 2016Publication date: January 26, 2017Applicant: Hemotek Medical IncorporatedInventors: Patrick ROUSCHE, Peter TEK, Charles VENTURA, Richard A. SCRIBNER